Associated with promising clinical outcomes, pharmacodynamic analysis of tumor tissues, blood samples and skin biopsies of 29 patients enrolled, revealed a significant decrease of phospho-Src, phospho-ERK and phospho-AKT in epidermal keratinocytes. The gene discussed is AKT1; the disease is neoplasm.